Rhythm Biosciences Ltd has released a press release.
Appendix 4C and Market Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Appendix 4E
- Strategic partnership with Know Your Lemons Foundation
- ColoSTAT Kit Validation Completion and NATA Submission
- Placement Prospectus
- Share Placement to Raise Up To $3.75 million
Later from Rhythm Biosciences
- Rhythm Initiates Commercialisation of ColoSTAT
- datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development
- Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting
- Quarterly Activities Report and Appendix 4C
- Rhythm Biosciences Signs Manufacturing Agreement
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences